• RCS Ottawa

With ‘Kalushi,’ South Africans finally get to portray themselves in a film about the anti-apartheid


One of the most unique features of a new South African biopic about an anti-apartheid hero earning accolades worldwide is the nationality of the people behind and in front of the camera: for a change, they’re South African.

Kalushi portrays the true story of Solomon Mahlangu, a 19-year-old hawker from Mamelodi, a large township just outside of Pretoria, who joined the South African liberation movement after being brutally beaten by apartheid police in 1976. The film tracks Mahlangu’s return to Johannesburg after training as a freedom fighter in Angola and his subsequent trial for a murder he did not commit. He was executed by hanging for the murder in 1979.

The film stars an entirely South African cast. That distinguishes it from a slate of international biopics in which national heroes were portrayed by foreigners like Morgan Freeman, Idris Elba, and Denzel Washington (the efforts of foreign actors to master South African accents is a source of ongoing entertainment in the country). The dialogue in Kalushi jumps between English, Zulu, Xhosa, Afrikaans and other dialects heard throughout South Africa, which has 11 official languages and where many locals converse in two or three.


#Africa

3 views0 comments

Recent Posts

See All

How should we Mask COVID-19?

Global coronavirus deaths have been falling—but scientists are worried that more infectious new variants of the virus may reverse those trends. As quickly as vaccines were developed, the virus has ev

How We Can Stop the Spread of COVID-19 By Christmas

We have a long road ahead before a vaccine is safe, effective and, most crucially, widely available. We need a multi-pronged public health strategy that includes a national testing plan that utilizes

mRNA the innovation behind Pfizer and Moderna vaccines

Messenger RNA (mRNA) is a pivotal molecule of life, involved in almost all aspects of cell biology. The last decade has seen improvements in the delivery of a new class of mRNA drugs. In molecular bi